Recently, a team led by Professor Wu Hua from the School of Basic Medical Sciences, Suzhou Medical College of Soochow University published a research paper in Nature Cancer.

Colorectal cancer is a highly prevalent malignant tumor of the digestive tract worldwide. This study reveals a novel mechanism by which intestinal epithelial GSK3β drives the polarization of TINs toward the immunosuppressive T3 subset through a “metabolic–epigenetic cascade” and promotes immune escape in colorectal cancer. Based on this finding, the research team proposed a therapeutic strategy combining GSK3β inhibitors with immune checkpoint blockade. The results show that the combination therapy with Tideglusib plus immune checkpoint inhibitors (anti‑PD‑1 combined with anti‑CTLA‑4) is markedly superior to monotherapy. It can effectively restore the anti-tumor capacity of CD8⁺ T cells and achieve stronger tumor control. This study provides a new therapeutic strategy for colorectal cancer with resistance to immunotherapy.
论文链接Paper Link:
https://www.nature.com/articles/s43018-026-01253-9